Biocon Elevates Dr Mandar Ghatnekar to CTO After Corporate Integration Move
This is a newly created, enterprise-wide role that reflects Biocon’s transformation into a fully integrated, global medicines company where technology, digital, data, and AI are core enablers of innovation, scale and access across the end-to-end value chain, said Dr. Mandar Ghatnekar, Biocon’s CTO.






















